The FGFR2 F276C VUS was identified as a result of targeted sequencing of a tumor from a 57-year-old male with advanced, multifocal, intrahepatic cholangiocarcinoma. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.